prikaz prve stranice dokumenta Basal and postprandial change in serum fibroblast growth factor-21 concentration in type 1 diabetic mellitus and in healthy controls
  Preuzmi
PDF 388.27 KB
Znanstveni rad - Izvorni znanstveni rad
Basal and postprandial change in serum fibroblast growth factor-21 concentration in type 1 diabetic mellitus and in healthy controls
Endocrine, 48 (2015), 3; 848-855. https://doi.org/10.1007/s12020-014-0413-9
Zibar, Karin; Blaslov, Kristina; Bulum, Tomislav; Knežević Ćuća, Jadranka; Smirčić-Duvnjak, Lea

Citirajte ovaj rad

Zibar, K., Blaslov, K., Bulum, T., Knežević Ćuća, J. i Smirčić Duvnjak, L. (2015). Basal and postprandial change in serum fibroblast growth factor-21 concentration in type 1 diabetic mellitus and in healthy controls. Endocrine, 48. (3), 848-855. doi: 10.1007/s12020-014-0413-9

Zibar, Karin, et al. "Basal and postprandial change in serum fibroblast growth factor-21 concentration in type 1 diabetic mellitus and in healthy controls." Endocrine, vol. 48, br. 3, 2015, str. 848-855. https://doi.org/10.1007/s12020-014-0413-9

Zibar, Karin, Kristina Blaslov, Tomislav Bulum, Jadranka Knežević Ćuća i Lea Smirčić Duvnjak. "Basal and postprandial change in serum fibroblast growth factor-21 concentration in type 1 diabetic mellitus and in healthy controls." Endocrine 48, br. 3 (2015): 848-855. https://doi.org/10.1007/s12020-014-0413-9

Zibar, K., et al. (2015) 'Basal and postprandial change in serum fibroblast growth factor-21 concentration in type 1 diabetic mellitus and in healthy controls', Endocrine, 48(3), str. 848-855. doi: 10.1007/s12020-014-0413-9

Zibar K, Blaslov K, Bulum T, Knežević Ćuća J, Smirčić Duvnjak L. Basal and postprandial change in serum fibroblast growth factor-21 concentration in type 1 diabetic mellitus and in healthy controls. Endocrine [Internet]. 04.2015. [pristupljeno 12.11.2024.];48(3):848-855. doi: 10.1007/s12020-014-0413-9

K. Zibar, K. Blaslov, T. Bulum, J. Knežević Ćuća i L. Smirčić Duvnjak, "Basal and postprandial change in serum fibroblast growth factor-21 concentration in type 1 diabetic mellitus and in healthy controls", Endocrine, vol. 48, br. 3, str. 848-855, Travanj 2015. [Online]. Dostupno na: https://urn.nsk.hr/urn:nbn:hr:105:835984. [Citirano: 12.11.2024.]

Za citiranje koristite ovu mrežnu adresu: https://urn.nsk.hr/urn:nbn:hr:105:835984
Prijavite se u repozitorij kako biste mogli spremiti objekt u svoju listu.
Podaci o radu
Naslov (engleski)Basal and postprandial change in serum fibroblast growth factor-21 concentration in type 1 diabetic mellitus and in healthy controls
AutorKarin Zibar
AutorKristina Blaslov
AutorTomislav Bulum
AutorJadranka Knežević Ćuća
AutorLea Smirčić-Duvnjak
Autorova ustanovaSveučilište u Zagrebu
Medicinski fakultet
Znanstveno / umjetničko
područje, polje i grana		BIOMEDICINA I ZDRAVSTVO
Kliničke medicinske znanosti
Sažetak (engleski)
Fibroblast growth factor-21 (FGF-21) appears to have an important role in glucose and lipid metabolism. FGF-21 secretion is mainly determined by nutritional status. The aim of this study was to measure basal and postprandial FGF-21 and postprandial change of FGF-21 concentration in type 1 diabetes mellitus (T1DM) patients and in healthy controls, and to investigate the differences between the groups. The cross-sectional study included 30 C-peptide negative T1DM patients, median age 37 years (20-59), disease duration 22 years (3-45), and nine healthy controls, median age 30 years (27-47). Basal and postprandial FGF-21 concentrations were measured by ELISA. The associations of FGF-21 with glucose, lipids, and insulin were analyzed. Individuals with T1DM showed significantly lower basal FGF-21 concentration (P=0.046) when compared with healthy controls (median value 28.2 vs 104 pg/mL) and had significantly different postprandial change (∆ 30'-0') of FGF-21 (P=0.006) in comparison with healthy controls (median value -1.1 vs -20.5 pg/mL). The glucose and lipid status did not correlate with FGF-21. In healthy controls, postprandial insulin level correlated with basal FGF-21 (ρ=0.7, P=0.036). Multiple regression analysis showed that they are independently associated after adjustment for confounding factors (β=1.824, P=0.04). We describe the pathological pattern of basal and postprandial change of FGF-21 secretion not associated with glucose, lipid levels, or insulin therapy in patients with T1DM. Since FGF-21 has numerous protective metabolic effects in the experimental model, the lower basal FGF-21 concentration in T1DM patients opens the question about the potential role of recombinant FGF-21 therapy.
Ključne riječi (engleski)
Jezikengleski
Vrsta publikacijeZnanstveni rad - Izvorni znanstveni rad
Status objaveObjavljen
Vrsta recenzijeRecenziran
Verzija publikacijeZavršna verzija rukopisa prihvaćena za objavljivanje (postprint)
Naslov časopisaEndocrine
Brojčani podacivol. 48, br. 3, str. 848-855
p-ISSN1355-008X
DOIhttps://doi.org/10.1007/s12020-014-0413-9
URN:NBNurn:nbn:hr:105:835984
Datum objave publikacije2015-04
URL dokumentahttps://doi.org/10.1007/s12020-014-0413-9
Vrsta resursaTekst
Prava pristupaOtvoreni pristup
Uvjeti korištenjaIkona licence Zaštićeno autorskim pravom.
Datum i vrijeme pohrane2024-03-28 08:15:13